Background: Remote diagnostic assessment of cognitively impaired individuals offers numerous potential benefits including increased access to care. However, remote cognitive and behavioral assessment also has limitations, and may not be appropriate for certain patients. Currently, evidence‐based guidance on virtual assessment readiness is lacking. Our goal was to develop a clinical decision‐making tool that outlines an approach to determining a patient’s suitability for undergoing remote cognitive and behavioral diagnostic assessment by identifying ‘red flags’ for remote assessment. To address this goal, a multidisciplinary workgroup was convened under the auspices of the Canadian Consortium on Neurodegeneration in Aging (CCNA). This workgroup was composed of experts in remote assessment and included behavioral neurologists, neuropsychiatrists, neuropsychologists, social workers, geriatricians, persons with lived experience and family medicine specialists.
Methods: The Delphi process is an iterative, systematic, group consensus method, used here to determine the features of the patient, caregiver, clinician and context/situation, or ‘red flags’, indicating that a remote cognitive diagnostic assessment should be avoided. The process consisted of anonymized data collection in three rounds among the multidisciplinary expert workgroup, culminating in two rounds of iterative scoring of potential red flags based on three quality indicators that assessed a potential red flag’s effectiveness, reproducibility, and efficiency. Red flags that received an overall mean score above the pre‐determined consensus threshold on the final round were included in the final clinical decision‐making tool.
Result: In the first round, 11 respondents, with an average of 12.4 years of clinical experience, generated 67 unique potential red flags. In the second and third rounds, 8 and 9 respondents, respectively, scored the flags on the three quality indicators. Applying consensus criteria yielded 14 red flags that achieved consensus.
Conclusion: To enhance the translation and implementation of these findings, we developed a clinical decision‐making tool and infographic describing the final set of red flags in collaboration with the CCNA knowledge translation team. This infographic is designed to help clinicians determine a patient’s readiness to undergo remote cognitive assessment. This study directly impacts the clinical care of cognitively impaired individuals by providing clinical decision‐making guidance on a patient’s suitability for remote neurobehavioral assessment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.088902 | DOI Listing |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11716106 | PMC |
Curr Cardiol Rep
January 2025
Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), European Reference Network for Rare, University of Trieste, Via P. Valdoni 7, 34100, Trieste, Italy.
Purpose Of Review: Hot phases are a challenging clinical presentation in arrhythmogenic cardiomyopathy (ACM), marked by acute chest pain and elevated cardiac troponins in the absence of obstructive coronary disease. These episodes manifest as myocarditis and primarily affect young patients, contributing to a heightened risk of life-threatening arrhythmias and potential disease progression. This review aims to synthesize recent research on the pathophysiology, diagnostic challenges, and therapeutic management of hot phases in ACM.
View Article and Find Full Text PDFBackground: Remote diagnostic assessment of cognitively impaired individuals offers numerous potential benefits including increased access to care. However, remote cognitive and behavioral assessment also has limitations, and may not be appropriate for certain patients. Currently, evidence‐based guidance on virtual assessment readiness is lacking.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Kathmandu University School of Medical Sciences, DHULIKHEL, Bagmati, Nepal
Background: Frailty is significantly associated with incidence of Alzheimer’s disease and dementia and death . The worldwide incidence of frailty and pre frailty was estimated as 43.4 and 150.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Audition Technology, Pittsburgh, PA, USA
The recent ACHIEVE study (https://www.achievestudy.org/) demonstrated the substantial benefit of hearing aid use in those with mild‐moderate hearing loss and at increased risk for cognitive decline.
View Article and Find Full Text PDFMuscle Nerve
January 2025
Service de Neurologie, Centre de Référence Neuropathies Périphériques Rares, Centre Hospitalier Universitaire de Limoges, Limoges, France.
Introduction/aims: Neurolymphomatosis is a hematological condition defined by the direct infiltration of malignant lymphomatous cells into the peripheral nervous system. Since nerve conduction studies may disclose demyelinating features, clinicians may misdiagnose neurolymphomatosis as chronic inflammatory demyelinating polyneuropathy (CIDP). This study aimed to determine whether patients with neurolymphomatosis met the 2021 revised criteria for CIDP.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!